XML 53 R40.htm IDEA: XBRL DOCUMENT v3.19.1
LICENSE AGREEMENTS (Details Textual)
1 Months Ended 12 Months Ended
Aug. 05, 2016
USD ($)
Jun. 20, 2018
USD ($)
Dec. 26, 2017
USD ($)
Feb. 27, 2015
USD ($)
Dec. 27, 2013
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2018
EUR (€)
Dec. 31, 2017
LICENSE AGREEMENTS [Line Items]                
Payments for Royalties | €             € 20,000  
Upfront Payment $ 2,500              
Reimbursed Expenses to be Paid     $ 50,000          
Written Notice Period           90 days 90 days 90 years
CSMC [Member]                
LICENSE AGREEMENTS [Line Items]                
Upfront Payment 2,500              
Reimbursed Expenses to be Paid 16,000              
Exosomes License Agreement [Member]                
LICENSE AGREEMENTS [Line Items]                
Upfront Payment       $ 20,000        
Additional Milestone Payment       190,000        
Reimbursed Expenses to be Paid   $ 27,000   34,000        
Janssen Agreement [Member]                
LICENSE AGREEMENTS [Line Items]                
Payment Received For Development Fee         $ 12,500,000      
CSMC Licence Agreement [Member]                
LICENSE AGREEMENTS [Line Items]                
Reimbursed Expenses to be Paid $ 10,000              
Minimum [Member]                
LICENSE AGREEMENTS [Line Items]                
Development Milestones           $ 350,000    
Maximum [Member]                
LICENSE AGREEMENTS [Line Items]                
Development Milestones           800,000    
Maximum [Member] | JHU License Agreement [Member]                
LICENSE AGREEMENTS [Line Items]                
Potential Milestone Payments           1,850,000    
Completion of Phase One [Member] | Exosomes License Agreement [Member]                
LICENSE AGREEMENTS [Line Items]                
Milestone Payments To Be Made Upon Successful Completion Of Certain Phases       15,000        
Completion of Phase One [Member] | Minimum [Member]                
LICENSE AGREEMENTS [Line Items]                
Range of Milestone Payments, Payable Upon Successful Completion of Certain Phases           100,000    
Obtention of FDA Approval [Member] | Exosomes License Agreement [Member]                
LICENSE AGREEMENTS [Line Items]                
Milestone Payments To Be Made Upon Successful Completion Of Certain Phases       $ 75,000        
Obtention of FDA Approval [Member] | Maximum [Member]                
LICENSE AGREEMENTS [Line Items]                
Range of Milestone Payments, Payable Upon Successful Completion of Certain Phases           1,000,000    
First and Second Anniversary [Member]                
LICENSE AGREEMENTS [Line Items]                
Payments for Royalties           5,000    
Tenth Anniversary and Thereafter [Member]                
LICENSE AGREEMENTS [Line Items]                
Payments for Royalties           $ 20,000